Rakuten Investment Management Inc. acquired a new position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The firm acquired 25,469 shares of the company’s stock, valued at approximately $9,992,000.
Several other hedge funds have also recently bought and sold shares of HCA. RB Capital Management LLC acquired a new position in HCA Healthcare during the second quarter valued at approximately $1,115,000. Glenview Trust Co acquired a new position in shares of HCA Healthcare during the 2nd quarter valued at $494,000. Empowered Funds LLC purchased a new stake in HCA Healthcare during the 2nd quarter worth $9,426,000. United Capital Financial Advisors LLC purchased a new position in HCA Healthcare in the second quarter valued at about $1,983,000. Finally, Caitlin John LLC purchased a new stake in shares of HCA Healthcare in the second quarter worth about $834,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.
HCA Healthcare Stock Performance
Shares of HCA Healthcare stock opened at $417.57 on Friday. The firm has a market cap of $90.40 billion, a PE ratio of 13.98, a price-to-earnings-growth ratio of 1.45 and a beta of 1.10. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The firm’s 50-day simple moving average is $401.08 and its 200-day simple moving average is $441.46.
HCA Healthcare Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s payout ratio is currently 10.45%.
Analyst Upgrades and Downgrades
Several research firms recently commented on HCA. Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Sanford C. Bernstein reiterated a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Raymond James Financial set a $528.00 price target on shares of HCA Healthcare in a report on Tuesday, July 7th. Oppenheimer cut their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a report on Monday, July 27th. Finally, Morgan Stanley dropped their target price on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $462.64.
View Our Latest Stock Report on HCA
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Stories
- Five stocks we like better than HCA Healthcare
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
